4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-24-000080
CHIEF EXECUTIVE OFFICER sold 7,098 shares at an average $109.21 ($775,154)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-10-07 | Sale 10b5-1 | −310 | $107.27 | $33,253 | 141,820 | I |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-10-07 | Sale 10b5-1 | −887 | $108.72 | $96,437 | 140,933 | I |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-10-07 | Sale 10b5-1 | −2,113 | $109.58 | $231,549 | 138,820 | I |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-10-07 | Sale 10b5-1 | −239 | $110.35 | $26,373 | 138,581 | I |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-10-07 | Sale 10b5-1 | −356 | $107.50 | $38,269 | 141,774 | I |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-10-07 | Sale 10b5-1 | −807 | $108.75 | $87,760 | 140,967 | I |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-10-07 | Sale 10b5-1 | −1,849 | $109.43 | $202,334 | 139,118 | I |
| PICKERING GRANT CHIEF EXECUTIVE OFFICER | 2024-10-07 | Sale 10b5-1 | −537 | $110.20 | $59,180 | 138,581 | I |
| Open-market sales · 7,098 sh · avg $109.21 · $775,154 | |||||||
Loading xslF345X05/wk-form4_1728433940.xml…